Overview of Prostate Cancer: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
</div> | </div> | ||
== Introduction == | == Introduction == | ||
Prostate cancer affects the prostate gland, which is part of the male reproductive system and functions to create seminal fluid. | |||
* In 2020, there were an estimated 1.4 million new cases of prostate cancer and 375,000 prostate cancer related deaths worldwide<ref name=":0">Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. [https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21660 Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.] CA: a cancer journal for clinicians. 2021 May;71(3):209-49.</ref> | |||
* Prostate cancer was the second most frequent cancer and the fifth leading cause of cancer death among men<ref name=":0" /> | |||
* It was the most frequently diagnosed cancer in men in over one-half of the countries of the world<ref name=":0" /> | |||
* Differences in prostate cancer diagnostic practices are most likely the greatest contributor to the worldwide variation in prostate cancer incidence rates<ref name=":0" /> | |||
* The majority of men diagnosed with prostate cancer have a slow growing variation of the disease that is nonthreatening to their natural life expectancy and can be safely monitored without need for medical intervention<ref name=":1">Tonry C, Finn S, Armstrong J, Pennington SR. [https://clinicalproteomicsjournal.biomedcentral.com/articles/10.1186/s12014-020-09305-7 Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management.] Clinical Proteomics. 2020 Dec;17(1):1-31.</ref> | |||
* For those men diagnosed with metastatic prostate cancer, only 28% will survive beyond five years of diagnosis<ref name=":1" /> | |||
== Anatomy Review == | == Anatomy Review == | ||
=== Characteristics/Clinical Presentation === | === Characteristics/Clinical Presentation === | ||
Prostate Cancer Symptoms | ==== Tumor Staging ==== | ||
==== Prostate Cancer Symptoms ==== | |||
Etiology/Causes | ==== Etiology/Causes ==== | ||
While the prevalence of prostate cancer is common, relatively little is known about its etiology.<ref name=":0" /> | |||
=== Associated Co-morbidities === | === Associated Co-morbidities === | ||
Revision as of 05:04, 14 April 2022
Original Editor - Stacy Schiurring based on the course by Pierre Roscher
Top Contributors - Stacy Schiurring, Kim Jackson, Lucinda hampton and Jess Bell
Introduction[edit | edit source]
Prostate cancer affects the prostate gland, which is part of the male reproductive system and functions to create seminal fluid.
- In 2020, there were an estimated 1.4 million new cases of prostate cancer and 375,000 prostate cancer related deaths worldwide[1]
- Prostate cancer was the second most frequent cancer and the fifth leading cause of cancer death among men[1]
- It was the most frequently diagnosed cancer in men in over one-half of the countries of the world[1]
- Differences in prostate cancer diagnostic practices are most likely the greatest contributor to the worldwide variation in prostate cancer incidence rates[1]
- The majority of men diagnosed with prostate cancer have a slow growing variation of the disease that is nonthreatening to their natural life expectancy and can be safely monitored without need for medical intervention[2]
- For those men diagnosed with metastatic prostate cancer, only 28% will survive beyond five years of diagnosis[2]
Anatomy Review[edit | edit source]
Characteristics/Clinical Presentation[edit | edit source]
Tumor Staging[edit | edit source]
Prostate Cancer Symptoms[edit | edit source]
Etiology/Causes[edit | edit source]
While the prevalence of prostate cancer is common, relatively little is known about its etiology.[1]
Associated Co-morbidities[edit | edit source]
Prostate Cancer Tests and Screenings[edit | edit source]
Treatment Options[edit | edit source]
Compare pro's and con's
Side effects/expected PT symptoms
Surgical Interventions[edit | edit source]
Radiation[edit | edit source]
Active Surveillance[edit | edit source]
Resources[edit | edit source]
- bulleted list
- x
or
- numbered list
- x
References[edit | edit source]
- ↑ 1.0 1.1 1.2 1.3 1.4 Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021 May;71(3):209-49.
- ↑ 2.0 2.1 Tonry C, Finn S, Armstrong J, Pennington SR. Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management. Clinical Proteomics. 2020 Dec;17(1):1-31.
